Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
11.275    0.00 (0.00%)
Bid:
10.80
Ask:
11.75
Spread: 0.95 (8.796%)
Market Cap: £31.38m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

VPC Impact Acquisition Holdings Sponsor III, LLC

7 Jun 2021 13:30

RNS Number : 0622B
VPC Specialty Lending Invest. PLC
07 June 2021
 

VPC Specialty Lending Investments PLC (the "Company")

 Update Regarding its Holding in VPC Impact Acquisition Holdings Sponsor III, LLC

 

The Company notes that earlier today, 7 June 2021, VPC Impact Acquisition Holdings III, Inc. (NYSE: VPCC) ("VPCC"), a special purpose acquisition company sponsored by VPC Impact Acquisition Holdings Sponsor III, LLC ("VPC Sponsor"), an affiliate of Victory Park Capital ("VPC"), announced it has entered into a definitive agreement to combine with Dave Inc. ("Dave") (https://www.dave.com/). For more information on the transaction please see the Dave and VPCC press release, which can be found here: https://www.victoryparkcapital.com/news/2021/06/07/dave-a-leading-banking-app-with-10-million-customers-announces-plans-to-become-publicly-traded-company-via-merger-with-vpc-impact-acquisition-holdings-iii-inc/. 

Through VPC Sponsor, VPC Specialty Lending Investments PLC ("VSL") currently owns 1,021,630 Class B Shares and 829,154 private placement warrants in VPCC, held at an aggregate cost basis of US$1,247,795. The transaction implies an approximately US$4 billion post-merger enterprise value at a US$10.00 price per Class A Common Stock. Upon the consummation of the transaction, 75% of VSL's Class B Shares shall be automatically converted into one share of Class A Common Stock of Dave with an aggregate undiscounted implied transaction value of US$7,662,230 to the Company representing a 1.6% increase to the 30 April 2021 NAV (before fees). The other 25% of VSL's Class B Shares have a vesting period of five years from the consummation of the transaction but are fully vested if the volume weighted average price ("VWAP") reaches defined levels for 20 out of 30 trading days at any time during this period. Of the remaining Class B Shares, 60% will vest at a VWAP of US$12.50 price per Class A Common Stock and the remaining 40% will vest at a VWAP of US$15.00 price per Class A Common Stock.

The Company will initially value the Class A Common Stock at the closing trade price and take a 30% discount to the value to take into account deal closing risk and illiquidity relating to the lock up on the Class A Common Stock. The discounted valuation above results in a value of US$5,363,561 representing a 1.0% increase to the 30 April 2021 NAV (before fees). There would be no value assigned to the remaining 25% of the Class B Shares until the shares have vested and convert into Class A Common Stock.

Similarly, each private placement warrant shall be converted into a warrant to purchase one share of Class A Common Stock of Dave. VSL holds 829,154 warrants, which maintain a US$11.50 per share strike price, provide for cashless exercise and expire five years after closing of the transaction. At a US$10.00 price per Class A Common Stock, there would be no value assigned to the private placement warrants as long as the Class A Common Stock traded price is below the strike price.

VSL's Class A Common Stock shall be subject to a one-year post-closing lockup unless otherwise accelerated based on average trading performance measured six months post-closing. The transaction is expected to close in the third quarter of 2021 and remains subject to VIH III shareholder approval amongst other closing conditions. 

The information contained in this announcement is inside information and is price sensitive.

 

Enquiries

 

For further information, please contact:

 

Victory Park Capital

Brendan Carroll (Senior Partner and Co-Founder)

Gordon Watson (Partner)

 

via Jefferies or Winterflood (below)

info@vpcspecialtylending.com

 

Jefferies International Limited

 

Tel: +44 20 7029 8000

Stuart Klein

Neil Winward

Gaudi le Roux

 

 

Winterflood Securities Limited

Tel: +44 20 3100 0000

Neil Morgan

Chris Mills

 

 

 

Link Company Matters Limited (Company Secretary)

 

Tel: +44 20 7954 9567

Email: VPC@linkgroup.co.uk

 

  

About VPC Specialty Lending Investments PLC

VPC Specialty Lending Investments PLC (Company No. 9385218) is a UK listed investment trust focused on asset-backed lending to emerging and established businesses with the goal of building long-term, sustainable income generation. The Company identifies investment opportunities across various industries and geographies to offer shareholders access to a diversified portfolio of opportunistic credit investments originated by non-bank lenders with a focus on the rapidly developing technology-enabled lending sector.

 

Further information on VPC Specialty Lending Investments PLC is available at: http://vpcspecialtylending.com.

 

LEI: 549300UPEXC5DQB81P34

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBUURAKUNRAR
Date   Source Headline
1st Jun 20217:00 amRNSNet Asset Value(s)
1st Jun 20217:00 amRNSTotal Voting Rights
24th May 20215:10 pmRNSTransaction in Own Shares
20th May 20215:24 pmRNSDividend Declaration
18th May 20215:21 pmRNSTransaction in Own Shares
18th May 20214:48 pmRNSNotice of Annual General Meeting
14th May 20215:21 pmRNSTransaction in Own Shares
13th May 20215:04 pmRNSTransaction in Own Shares
12th May 20215:24 pmRNSTransaction in Own Shares
6th May 20215:22 pmRNSTransaction in Own Shares
4th May 202110:17 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSAnnual Financial Report
28th Apr 20213:00 pmRNSNet Asset Value(s)
21st Apr 20215:21 pmRNSTransaction in Own Shares
20th Apr 20215:43 pmRNSTransaction in Own Shares
20th Apr 20211:57 pmRNSHolding(s) in Company
8th Apr 20215:40 pmRNSTransaction in Own Shares
7th Apr 20215:22 pmRNSTransaction in Own Shares
7th Apr 20217:00 amRNSNet Asset Value(s)
1st Apr 20219:14 amRNSTotal Voting Rights
29th Mar 202110:05 amRNSDirector/PDMR Shareholding
26th Mar 20215:14 pmRNSTransaction in Own Shares
19th Mar 20215:22 pmRNSTransaction in Own Shares
19th Mar 20212:30 pmRNSAnnual Letter
11th Mar 20215:15 pmRNSTransaction in Own Shares
11th Mar 20219:56 amRNSAppointment of Audit and Valuation Committee Chair
10th Mar 20215:27 pmRNSTransaction in Own Shares
9th Mar 20215:32 pmRNSTransaction in Own Shares
3rd Mar 20215:36 pmRNSTransaction in Own Shares
3rd Mar 20214:20 pmRNSTransaction in Own Shares
3rd Mar 20217:00 amRNSNet Asset Value(s)
1st Mar 202112:43 pmRNSTotal Voting Rights
26th Feb 20215:19 pmRNSTransaction in Own Shares
25th Feb 20214:26 pmRNSAppointment of Chairman Designate
25th Feb 20217:00 amRNSDividend Declaration
19th Feb 20215:04 pmRNSTransaction in Own Shares
18th Feb 20215:32 pmRNSTransaction in Own Shares
17th Feb 20215:09 pmRNSTransaction in Own Shares
16th Feb 20215:09 pmRNSTransaction in Own Shares
15th Feb 20215:05 pmRNSTransaction in Own Shares
3rd Feb 20217:00 amRNSNet Asset Value(s)
11th Jan 20211:08 pmRNSUpdate re VPC Impact Acquisition Holdings Sponsor
4th Jan 202111:51 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSNet Asset Value(s)
10th Dec 20205:13 pmRNSDirector/PDMR Shareholding
10th Dec 20205:02 pmRNSTransaction in Own Shares
9th Dec 20205:17 pmRNSTransaction in Own Shares
2nd Dec 20203:30 pmRNSDirector/PDMR Shareholding
1st Dec 202012:04 pmRNSTotal Voting Rights
26th Nov 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.